Mandala Painting During Chemotherapy

NCT07269340 | Recruiting

• 1 other identifier: TPDD-2025-2369
• Study Type: interventional
• Target: 120
• Locations: 1 country
• Sites: 1

Brief Summary

In addition to managing drug side effects that arise during cancer treatment, maintaining the patient's psychosocial well-being is also very important. Therefore, the aim of this project is to examine the effect of mandala painting during chemotherapy on anxiety, nausea, and comfort levels. This project aims to reduce the negative effects of chemotherapy, such as nausea, anxiety, and decreased comfort, by distracting the patient's attention through the non-invasive and non-pharmacological practice of mandala coloring in patients undergoing chemotherapy. Mandala painting is a distraction and positive focus practice. A limited number of studies conducted on cancer patients have shown that it reduces distress and improves psychological well-being. However, no study in the literature has comprehensively addressed the symptoms experienced by patients during chemotherapy, such as anxiety, nausea, intense stress, and impaired comfort. The research will be conducted on patients undergoing chemotherapy for the first time, and patients in the experimental group will engage in mandala coloring for at least 30 minutes. Data obtained from assessments conducted before and after chemotherapy will be compared with control group data. This project will provide a more comprehensive assessment of the effect of mandala painting, a non-pharmacological intervention, on the negative symptoms of patients undergoing chemotherapy for the first time. In addition to its scientific contribution, it is believed that effective symptom management can contribute to patients' well-being. Furthermore, if nausea can be controlled, the need for antiemetics during treatment can be reduced. This will also contribute to reducing unwanted drug effects and lowering costs.

Conditions

Mandala Painting; Chemotherapy; Vomiting; Anxiety; Comfort; Nursing Care

Outcome Measures

Primary Outcomes (1)

• Change from baseline Anxiety level

  Baseline and post-intervention anxiety level assessed by trained research nurse using Spielberg's State-Trait Anxiety Inventory (STAI). The test scores between 20 and 80, with higher scores indicating more generalized and stronger anxiety.

  baseline, 60-120 minute

Secondary Outcomes (3)

• Nausea level

  baseline, 60-120 minute

• Satisfaction level

  60-120 minute

• Comfort level

  baseline, 60-120 minute

Study Arms (2)

Mandala Painting

EXPERIMENTAL

Patients receiving chemotherapy for the first time will have mandala painting done during their chemotherapy treatment.

Other: mandala painting

Control Group

NO INTERVENTION

The patients in this group will not receive any intervention and will receive standard treatment and care during chemotherapy.

Interventions

mandala painting OTHER

art therapy: mandala painting

Mandala Painting

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• \> 18 years old,
• Receiving chemotherapy for the first time

You may not qualify if:

• Have a lower education level than secondary school (The STAI is appropriate for those who have at least a sixth-grade reading level),
• Diagnosed with psychiatric and neurological diseases,
• Diagnosed with dementia,
• Received chemotherapy treatment more than once,
• Planned to receive radiotherapy treatment together with chemotherapy.

Sponsors & Collaborators

• Uludag University: lead

Study Sites (1)

Bursa Uludağ University

Bursa, 16059, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Vomiting; Anxiety Disorders

Condition Hierarchy (Ancestors)

Signs and Symptoms, Digestive; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Mental Disorders

Central Study Contacts

Seda Pehlivan

CONTACT

+902242942462; pehlivans@uludag.edu.tr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate professor

Study Record Dates

• First Submitted: November 24, 2025
• First Posted: December 8, 2025
• Study Start: September 9, 2025
• Primary Completion: April 1, 2026
• Study Completion (Estimated): May 1, 2026
• Last Updated: December 8, 2025

Record last verified: 2025-05

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)